SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
128.80    4.60 (3.70%)
Bid:
128.20
Ask:
129.60
Spread: 1.40 (1.092%)
Market Cap: £536.34m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Trading Update

29 Jan 2026 07:00

RNS Number : 7985Q
James Halstead PLC
29 January 2026
 

29 January 2026

 

 

JAMES HALSTEAD PLC (the "Company")

 

Trading Update

James Halstead plc, the commercial flooring manufacturer and international distributor, is providing the following trading update ahead of its interim results for the half year to 31 December 2025.

Sales for the first half of the year will see a small reduction in comparatives, as noted at the Annual General Meeting in December 2025, Central European and Asia Pacific markets remain challenging and have impacted on the overall total sales. UK sales remain robust and marginally up on last year despite the uncertain market conditions, and once again we have seen further growth in the North American and Middle Eastern markets. An uplift in sales to our South African distributor has also been pleasing.

As noted in the outlook of our Annual Report and Accounts to 30 June 2025, our conservative approach to customer credit has also been a factor in lower revenue across some markets, including the UK.

Looking ahead, the Company is confident that new and updated product ranges produced in the UK factories will see an uplift in revenue and there remains sufficient spare capacity at these factories for any significant uplift in volumes. The Expona Commercial collection in Germany has also been updated and relaunched with favourable reviews, and early sales into the market have been encouraging. 

There have been changes in senior management in our APAC region, and we believe the greater focus on top line growth because of these changes will see an improvement in both revenue and profitability over the second half of the year in this region.

Consequent to the imposition of stricter credit limits, noted above, this not only affected revenue but profitability will also see a small reduction on comparatives for the first 6 months, though the Board remains positive for the second half of the year.

The Company has seen an increase in cash balances over the first half of the year, remains ungeared and continues to invest in our UK sites for the future.

The Company expects to announce its results for the half-year ended 31 December 2025 on 31 March 2026.

 

 

 

 

Enquiries:

 

James Halstead plc

Tel: 0161 767 2500

Gordon Oliver, Chief Executive

David Drillingcourt, Finance Director

 

Hudson Sandler

Tel: 020 7796 4133

Nick Lyon / Nick Moore

Panmure Liberum (Nomad and Joint Broker)

Tel: 020 7886 2500

Ed Mansfield / Tom Scrivens

Zeus (Joint Broker)

Ben Thorne / Fraser Marshall

 

Tel: 020 3829 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTAKFBBOBKDDDB
Date   Source Headline
6th Dec 20198:30 amRNSAGM Statement
18th Oct 20199:51 amRNSNotice of Results
1st Oct 20197:00 amRNSPreliminary Results
18th Sep 20197:00 amRNSNotice of Preliminary Results
23rd Aug 20194:37 pmRNSPrice Monitoring Extension
30th Jul 20197:00 amRNSPre-Close Trading Statement
3rd Jul 20194:41 pmRNSNew Corporate Website
3rd Jun 201910:31 amRNSTotal Voting Rights
15th May 20198:08 amRNSDirector/PDMR Shareholding
10th May 20192:36 pmRNSDirector/PDMR Shareholding
3rd May 20192:07 pmRNSTotal Voting Rights
2nd Apr 20199:57 amRNSBlock listing Interim Review
1st Apr 20196:19 pmRNSTotal Voting Rights
29th Mar 20197:00 amRNSInterim Results
28th Mar 20191:24 pmRNSNotice of Interim Results - Update
25th Mar 20199:35 amRNSNotice of Interim Results
30th Jan 20197:00 amRNSPre Close Trading Statement
28th Jan 20191:16 pmRNSDirector/PDMR Shareholding
7th Dec 20184:13 pmRNSResult of AGM
7th Dec 20187:00 amRNSAGM Statement
19th Oct 20184:02 pmRNSAnnual Financial Report and Notice of AGM
19th Oct 20187:00 amRNSDirector/PDMR Shareholding
18th Oct 20187:00 amRNSAdditional Listing
18th Oct 20187:00 amRNSTotal Voting Rights
16th Oct 20186:13 pmRNSBlock listing Interim Review
27th Sep 20184:48 pmRNSDirector/PDMR Shareholding
26th Sep 20187:00 amRNSPreliminary Results
17th Sep 20187:00 amRNSNotice of Preliminary Results
25th Jul 20187:00 amRNSPre-Close Trading Statement
22nd May 20184:58 pmRNSRule 2.8 Announcement
22nd May 20189:39 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
21st May 20189:46 amRNSForm 8.3 - James Halstead
18th May 20182:52 pmRNSForm 8.3 - James Halstead
18th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
17th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
17th May 20187:57 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
16th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
15th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
14th May 201811:57 amRNSForm 8.5 (EPT/NON-RI)
11th May 20183:26 pmRNSDirector/PDMR Shareholding
11th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
11th May 201810:20 amRNSForm 8.3 - James Halstead
11th May 20189:07 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
10th May 20181:36 pmRNSDirector/PDMR Shareholding
10th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
10th May 20189:12 amRNSForm 8.3 - James Halstead
9th May 20183:29 pmBUSForm 8.3 - James Halstead PLC
9th May 201811:57 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
9th May 201811:57 amRNSForm 8.5 (EPT/NON-RI)
8th May 20181:22 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.